Clinical Oncology Next Generation Sequencing (NGS) Market Report

Global and China Clinical Oncology Next Generation Sequencing (NGS) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 09, 2022
  • PAGES：220
  • REPORT CODE：GMM1358339
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Clinical Oncology Next Generation Sequencing (NGS) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Illumina

    • Knome

    • CLC Bio

    • Myriad Genetics

    • Macrogen

    • Foundation Medicine

    • Qiagen

    • Roche

    • Life Technologies

    • Caris Life Sciences

    • Biomatters

    • Oxford Nanopore Technologies

    • Perkin Elmer

    • Agilent Technologies

    • Pacific Bioscience

    • Exosome Diagnostics

    • BGI

    • GATC Biotech

    • Genomatix Software

    • Paradigm

    • GnuBIO

    • DNASTAR

    • Partek

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • NGS Pre-Sequencing

    • Sequencing

    • NGS Data Analysis

    • Primary, Secondary & Tertiary Data Analysis

    Application:

    • Academic & Clinical Research

    • Hospitals & Clinics

    • Pharma & Biotech Entities

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Overview

      • 1.1.1 Clinical Oncology Next Generation Sequencing (NGS) Market Scope and Market Segments

      • 1.1.2 Clinical Oncology Next Generation Sequencing (NGS) Industry Characteristics

      • 1.1.3 Global and China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Clinical Oncology Next Generation Sequencing (NGS) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 NGS Pre-Sequencing

      • 1.2.2 Sequencing

      • 1.2.3 NGS Data Analysis

      • 1.2.4 Primary, Secondary & Tertiary Data Analysis

    • 1.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Academic & Clinical Research

      • 1.3.2 Hospitals & Clinics

      • 1.3.3 Pharma & Biotech Entities

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Clinical Oncology Next Generation Sequencing (NGS) Industry PEST Analysis

    • 2.3 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Clinical Oncology Next Generation Sequencing (NGS) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Clinical Oncology Next Generation Sequencing (NGS) Industry

    Chapter 3 Global and China Clinical Oncology Next Generation Sequencing (NGS) Market, by Manufacturer

    • 3.1 Global and China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Clinical Oncology Next Generation Sequencing (NGS) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Clinical Oncology Next Generation Sequencing (NGS) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Clinical Oncology Next Generation Sequencing (NGS) Market Top 3 Players

    Chapter 4 Global and China Clinical Oncology Next Generation Sequencing (NGS) Market, by Type (2017-2028)

    • 4.1 Clinical Oncology Next Generation Sequencing (NGS) Market Trend, by Type

    • 4.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Clinical Oncology Next Generation Sequencing (NGS) Price Trend, by Type (2017-2028)

    • 4.3 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Clinical Oncology Next Generation Sequencing (NGS) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Clinical Oncology Next Generation Sequencing (NGS) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 7.1 North America Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 7.2 North America Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    • 7.3 North America Clinical Oncology Next Generation Sequencing (NGS) Market Analysis and Forecast, by Country

      • 7.3.1 United States Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 8.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 8.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    • 8.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 9.1 APAC Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 9.2 APAC Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    • 9.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Analysis and Forecast, by Country

      • 9.3.1 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 10.1 Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 10.2 Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    • 10.3 Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Clinical Oncology Next Generation Sequencing (NGS) Company Profiles

      • 11.1 Illumina

        • 11.1.1 Illumina Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Knome

        • 11.2.1 Knome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.2.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 CLC Bio

        • 11.3.1 CLC Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.3.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Myriad Genetics

        • 11.4.1 Myriad Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.4.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Macrogen

        • 11.5.1 Macrogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.5.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Foundation Medicine

        • 11.6.1 Foundation Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.6.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Qiagen

        • 11.7.1 Qiagen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.7.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Roche

        • 11.8.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.8.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Life Technologies

        • 11.9.1 Life Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Caris Life Sciences

        • 11.10.1 Caris Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.10.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Biomatters

        • 11.11.1 Biomatters Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.11.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Oxford Nanopore Technologies

        • 11.12.1 Oxford Nanopore Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.12.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Perkin Elmer

        • 11.13.1 Perkin Elmer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.13.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Agilent Technologies

        • 11.14.1 Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.14.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Pacific Bioscience

        • 11.15.1 Pacific Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.15.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Exosome Diagnostics

        • 11.16.1 Exosome Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.16.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 BGI

        • 11.17.1 BGI Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.17.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 GATC Biotech

        • 11.18.1 GATC Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.18.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Genomatix Software

        • 11.19.1 Genomatix Software Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.19.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Paradigm

        • 11.20.1 Paradigm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.20.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 GnuBIO

        • 11.21.1 GnuBIO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.21.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 DNASTAR

        • 11.22.1 DNASTAR Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.22.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.23 Partek

        • 11.23.1 Partek Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.23.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Profiles, Application and Specification

        • 11.23.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Clinical Oncology Next Generation Sequencing (NGS) Industry Investment Prospect and Risk Assessment

    • 12.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Clinical Oncology Next Generation Sequencing (NGS) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Production Value and Growth Rate (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Value and Growth Rate (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of NGS Pre-Sequencing (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Sequencing (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of NGS Data Analysis (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Primary, Secondary & Tertiary Data Analysis (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Academic & Clinical Research (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Hospitals & Clinics (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Pharma & Biotech Entities (2017-2028)

    • Figure North America Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Clinical Oncology Next Generation Sequencing (NGS) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Clinical Oncology Next Generation Sequencing (NGS) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Clinical Oncology Next Generation Sequencing (NGS) Market Share, by Manufacturer in 2021

    • Figure Global and China Clinical Oncology Next Generation Sequencing (NGS) Market Share, by Manufacturer in 2022

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Type (2017-2028)

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Sales Value, by Type (2017-2028)

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Sales Value Share, by Type (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Price Trend, by Type (2017-2028)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Type (2017-2028)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Value, by Type (2017-2028)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Value Share, by Type (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Price Trend, by Type (2017-2028)

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Application (2017-2028)

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Sales Value, by Application (2017-2028)

    • Table Global Clinical Oncology Next Generation Sequencing (NGS) Sales Value Share, by Application (2017-2028)

    • Figure Global Clinical Oncology Next Generation Sequencing (NGS) Sales Value Share, by Application (2017-2028)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Application (2017-2028)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Value, by Application (2017-2028)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Value Share, by Application (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Value Share, by Application (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Production, Import, Consumption and Export (2017-2022)

    • Table North America Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Type (2017-2028)

    • Table North America Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Figure North America Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Table North America Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Application (2017-2028)

    • Table North America Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure North America Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure United States Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Table Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Type (2017-2028)

    • Table Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Table Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Application (2017-2028)

    • Table Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure UK Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure France Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure France Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Table APAC Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Type (2017-2028)

    • Table APAC Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Table APAC Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Application (2017-2028)

    • Table APAC Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure India Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure India Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Clinical Oncology Next Generation Sequencing (NGS) Sales Value and Growth Rate (2017-2028)

    • Table Illumina Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Illumina Product Profiles, Application and Specification

    • Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Knome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Knome Product Profiles, Application and Specification

    • Table Knome Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CLC Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CLC Bio Product Profiles, Application and Specification

    • Table CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Myriad Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Myriad Genetics Product Profiles, Application and Specification

    • Table Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Macrogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Macrogen Product Profiles, Application and Specification

    • Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Foundation Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Foundation Medicine Product Profiles, Application and Specification

    • Table Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Qiagen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Qiagen Product Profiles, Application and Specification

    • Table Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Life Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Life Technologies Product Profiles, Application and Specification

    • Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Caris Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Caris Life Sciences Product Profiles, Application and Specification

    • Table Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biomatters Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biomatters Product Profiles, Application and Specification

    • Table Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Oxford Nanopore Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Oxford Nanopore Technologies Product Profiles, Application and Specification

    • Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Perkin Elmer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Perkin Elmer Product Profiles, Application and Specification

    • Table Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agilent Technologies Product Profiles, Application and Specification

    • Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pacific Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pacific Bioscience Product Profiles, Application and Specification

    • Table Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Exosome Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Exosome Diagnostics Product Profiles, Application and Specification

    • Table Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BGI Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BGI Product Profiles, Application and Specification

    • Table BGI Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GATC Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GATC Biotech Product Profiles, Application and Specification

    • Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genomatix Software Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genomatix Software Product Profiles, Application and Specification

    • Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Paradigm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Paradigm Product Profiles, Application and Specification

    • Table Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GnuBIO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GnuBIO Product Profiles, Application and Specification

    • Table GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table DNASTAR Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table DNASTAR Product Profiles, Application and Specification

    • Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Partek Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Partek Product Profiles, Application and Specification

    • Table Partek Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US